US Stock MarketDetailed Quotes

enGene Therapeutics (ENGN)

Watchlist
  • 1.540
  • +0.100+6.94%
Close May 13 16:00 ET
  • 1.541
  • +0.001+0.05%
Pre 08:14 ET
103.16MMarket Cap-0.66P/E (TTM)

enGene Therapeutics (ENGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
17.18%31.19M
97.71%123.17M
126.19%39.48M
78.69%29.95M
56.70%27.12M
147.03%26.61M
139.05%62.3M
67.16%17.46M
168.23%16.76M
265.42%17.31M
Selling and administrative expenses
34.51%8.93M
19.61%28.69M
4.65%10.02M
42.65%6.68M
-1.77%5.98M
82.69%6.64M
183.14%23.98M
116.04%9.58M
176.55%4.68M
336.03%6.09M
-General and administrative expense
34.51%8.93M
19.61%28.69M
4.65%10.02M
42.65%6.68M
-1.77%5.98M
82.69%6.64M
183.14%23.98M
116.04%9.58M
176.55%4.68M
336.03%6.09M
Research and development costs
11.42%22.26M
146.59%94.48M
181.40%31.72M
95.47%22.58M
105.06%20.21M
254.27%19.97M
132.80%38.32M
98.78%11.27M
196.05%11.55M
206.53%9.86M
Other operating expenses
----
----
----
31.25%693K
-31.58%936K
-57.63%636K
65.99%1.88M
-550.45%-1.52M
-19.27%528K
985.71%1.37M
Operating profit
-17.18%-31.19M
-97.71%-123.17M
-126.19%-39.48M
-78.69%-29.95M
-56.70%-27.12M
-147.03%-26.61M
-139.05%-62.3M
-67.16%-17.46M
-168.23%-16.76M
-265.42%-17.31M
Net non-operating interest income expense
1.52%2.01M
-15.54%6.43M
-45.99%1.23M
-43.90%1.48M
-22.25%1.75M
328.14%1.98M
298.51%7.62M
401.60%2.27M
350.86%2.63M
319.46%2.26M
Non-operating interest income
0.37%2.74M
-9.48%9.43M
-34.69%1.98M
-33.93%2.23M
-16.62%2.49M
166.34%2.73M
832.23%10.41M
643.00%3.02M
757.87%3.38M
1,902.68%2.98M
Non-operating interest expense
-2.66%732K
7.01%2.99M
-0.79%750K
0.93%758K
0.82%734K
33.57%752K
-43.51%2.8M
-34.77%756K
-47.92%751K
-38.15%728K
Other net income (expense)
-1,654.05%-575K
-18.79%-569K
-30.11%-121K
-495.74%-280K
-325.27%-205K
108.60%37K
99.32%-479K
99.87%-93K
-101.82%-47K
-81.16%91K
Special income (charges)
---488K
--0
--0
--0
--0
--0
88.16%-366K
--0
--0
--0
-Less:Other special charges
--488K
----
----
----
----
----
-88.16%366K
--0
----
----
Other non- operating income (expenses)
-335.14%-87K
-403.54%-569K
-30.11%-121K
-495.74%-280K
-325.27%-205K
157.81%37K
99.80%-113K
99.82%-93K
98.61%-47K
-54.27%91K
Income before tax
-20.95%-29.75M
-112.65%-117.3M
-151.16%-38.38M
-102.81%-28.75M
-70.92%-25.58M
-129.01%-24.6M
44.78%-55.16M
81.47%-15.28M
-200.36%-14.18M
-183.28%-14.96M
Income tax
0
0
-2,715.79%-497K
924.14%239K
1,042.86%240K
160.00%18K
-211.76%-19K
11.76%19K
-29K
21K
Net income
-20.86%-29.75M
-112.73%-117.3M
-147.60%-37.88M
-104.91%-28.99M
-72.28%-25.82M
-129.82%-24.62M
44.81%-55.14M
81.46%-15.3M
-199.75%-14.15M
-183.68%-14.98M
Net income continuous Operations
-20.86%-29.75M
-112.73%-117.3M
-147.60%-37.88M
-104.91%-28.99M
-72.28%-25.82M
-129.82%-24.62M
44.81%-55.14M
81.46%-15.3M
-199.75%-14.15M
-183.68%-14.98M
Minority interest income
Net income attributable to the parent company
-20.86%-29.75M
-112.73%-117.3M
-147.60%-37.88M
-104.91%-28.99M
-72.28%-25.82M
-129.82%-24.62M
44.81%-55.14M
81.46%-15.3M
-199.75%-14.15M
-183.68%-14.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.86%-29.75M
-112.73%-117.3M
-147.60%-37.88M
-104.91%-28.99M
-72.28%-25.82M
-129.82%-24.62M
47.35%-55.14M
81.70%-15.3M
-136.08%-14.15M
-132.06%-14.98M
Basic earnings per share
8.33%-0.44
-56.85%-2.29
-114.71%-0.73
-78.13%-0.57
-34.21%-0.51
-4.35%-0.48
67.66%-1.46
90.56%-0.34
-23.87%-0.32
-36.52%-0.38
Diluted earnings per share
8.33%-0.44
-56.85%-2.29
-114.71%-0.73
-78.13%-0.57
-34.21%-0.51
-4.35%-0.48
67.66%-1.46
90.56%-0.34
-23.87%-0.32
-36.52%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 17.18%31.19M97.71%123.17M126.19%39.48M78.69%29.95M56.70%27.12M147.03%26.61M139.05%62.3M67.16%17.46M168.23%16.76M265.42%17.31M
Selling and administrative expenses 34.51%8.93M19.61%28.69M4.65%10.02M42.65%6.68M-1.77%5.98M82.69%6.64M183.14%23.98M116.04%9.58M176.55%4.68M336.03%6.09M
-General and administrative expense 34.51%8.93M19.61%28.69M4.65%10.02M42.65%6.68M-1.77%5.98M82.69%6.64M183.14%23.98M116.04%9.58M176.55%4.68M336.03%6.09M
Research and development costs 11.42%22.26M146.59%94.48M181.40%31.72M95.47%22.58M105.06%20.21M254.27%19.97M132.80%38.32M98.78%11.27M196.05%11.55M206.53%9.86M
Other operating expenses ------------31.25%693K-31.58%936K-57.63%636K65.99%1.88M-550.45%-1.52M-19.27%528K985.71%1.37M
Operating profit -17.18%-31.19M-97.71%-123.17M-126.19%-39.48M-78.69%-29.95M-56.70%-27.12M-147.03%-26.61M-139.05%-62.3M-67.16%-17.46M-168.23%-16.76M-265.42%-17.31M
Net non-operating interest income expense 1.52%2.01M-15.54%6.43M-45.99%1.23M-43.90%1.48M-22.25%1.75M328.14%1.98M298.51%7.62M401.60%2.27M350.86%2.63M319.46%2.26M
Non-operating interest income 0.37%2.74M-9.48%9.43M-34.69%1.98M-33.93%2.23M-16.62%2.49M166.34%2.73M832.23%10.41M643.00%3.02M757.87%3.38M1,902.68%2.98M
Non-operating interest expense -2.66%732K7.01%2.99M-0.79%750K0.93%758K0.82%734K33.57%752K-43.51%2.8M-34.77%756K-47.92%751K-38.15%728K
Other net income (expense) -1,654.05%-575K-18.79%-569K-30.11%-121K-495.74%-280K-325.27%-205K108.60%37K99.32%-479K99.87%-93K-101.82%-47K-81.16%91K
Special income (charges) ---488K--0--0--0--0--088.16%-366K--0--0--0
-Less:Other special charges --488K---------------------88.16%366K--0--------
Other non- operating income (expenses) -335.14%-87K-403.54%-569K-30.11%-121K-495.74%-280K-325.27%-205K157.81%37K99.80%-113K99.82%-93K98.61%-47K-54.27%91K
Income before tax -20.95%-29.75M-112.65%-117.3M-151.16%-38.38M-102.81%-28.75M-70.92%-25.58M-129.01%-24.6M44.78%-55.16M81.47%-15.28M-200.36%-14.18M-183.28%-14.96M
Income tax 00-2,715.79%-497K924.14%239K1,042.86%240K160.00%18K-211.76%-19K11.76%19K-29K21K
Net income -20.86%-29.75M-112.73%-117.3M-147.60%-37.88M-104.91%-28.99M-72.28%-25.82M-129.82%-24.62M44.81%-55.14M81.46%-15.3M-199.75%-14.15M-183.68%-14.98M
Net income continuous Operations -20.86%-29.75M-112.73%-117.3M-147.60%-37.88M-104.91%-28.99M-72.28%-25.82M-129.82%-24.62M44.81%-55.14M81.46%-15.3M-199.75%-14.15M-183.68%-14.98M
Minority interest income
Net income attributable to the parent company -20.86%-29.75M-112.73%-117.3M-147.60%-37.88M-104.91%-28.99M-72.28%-25.82M-129.82%-24.62M44.81%-55.14M81.46%-15.3M-199.75%-14.15M-183.68%-14.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.86%-29.75M-112.73%-117.3M-147.60%-37.88M-104.91%-28.99M-72.28%-25.82M-129.82%-24.62M47.35%-55.14M81.70%-15.3M-136.08%-14.15M-132.06%-14.98M
Basic earnings per share 8.33%-0.44-56.85%-2.29-114.71%-0.73-78.13%-0.57-34.21%-0.51-4.35%-0.4867.66%-1.4690.56%-0.34-23.87%-0.32-36.52%-0.38
Diluted earnings per share 8.33%-0.44-56.85%-2.29-114.71%-0.73-78.13%-0.57-34.21%-0.51-4.35%-0.4867.66%-1.4690.56%-0.34-23.87%-0.32-36.52%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More